Physicochemical characterization of GBV-C E1 peptides as potential inhibitors of HIV-1 fusion peptide: Interaction with model membranes

dc.contributor.author
Sánchez Martín, Ma. Jesús
dc.contributor.author
Cruz, Antonio
dc.contributor.author
Busquets i Viñas, Ma. Antonia
dc.contributor.author
Haro, Isabel
dc.contributor.author
Alsina Esteller, Ma. Asunción
dc.contributor.author
Pujol Cubells, Montserrat
dc.date.issued
2020-06-04T07:52:38Z
dc.date.issued
2020-06-04T07:52:38Z
dc.date.issued
2012-08
dc.date.issued
2020-06-04T07:52:38Z
dc.identifier
0378-5173
dc.identifier
https://hdl.handle.net/2445/164194
dc.identifier
617951
dc.description.abstract
Four peptide sequences corresponding to the E1 protein of GBV-C: NCCAPEDIGFCLEGGCLV (P7), APEDIGFCLEGGCLVALG (P8), FCLEGGCLVALGCTICTD (P10) and QAGLAVRPGKSAAQLVGE (P18) were studied as they were capable of interfering with the HIV-1 fusion peptide (HIV-1 FP). In this work, the surface properties of the E1 peptide sequences are investigated and their physicochemical characterization is done by studying their interaction with model membranes; moreover, their mixtures with HIV-1 FP were also studied in order to observe whether they are capable to modify the HIV-1 FP interaction with model membranes as liposomes or monolayers. Physicochemical properties of peptides (pI and net charge) were predicted showing similarities between P7 and P8, and P10 and HIV-1 FP, whereas P18 appears to be very different from the rest. Circular dichroism experiments were carried out showing an increase of the percentage of α-helix of P7 and P8 when mixed with HIV-1 FP corroborating a conformational change that could be the cause of their inhibition ability. Penetration experiments show that all the peptides can spontaneously insert into phospholipid membranes. Analysis of compression isotherms indicates that the peptides interact with phospholipids and the E1 peptides modify the compression isotherms of HIV-1 FP, but there is one of the peptides that excelled as the best candidate for inhibiting the activity of HIV-1 FP, P7, and therefore, that could be potentially used in future anti-HIV-1 research.
dc.format
9 p.
dc.format
application/pdf
dc.format
application/pdf
dc.language
eng
dc.publisher
Elsevier B.V.
dc.relation
Versió postprint del document publicat a: https://doi.org/10.1016/j.ijpharm.2012.07.051
dc.relation
International Journal of Pharmaceutics, 2012, vol. 436, num. 1-2, p. 593-601
dc.relation
https://doi.org/10.1016/j.ijpharm.2012.07.051
dc.rights
(c) Elsevier B.V., 2012
dc.rights
info:eu-repo/semantics/openAccess
dc.source
Articles publicats en revistes (Farmàcia, Tecnologia Farmacèutica i Fisicoquímica)
dc.subject
Pèptids
dc.subject
Síntesi de pèptids
dc.subject
Virus de l'hepatitis C
dc.subject
VIH (Virus)
dc.subject
Peptides
dc.subject
Peptide synthesis
dc.subject
Hepatitis C virus
dc.subject
HIV (Viruses)
dc.title
Physicochemical characterization of GBV-C E1 peptides as potential inhibitors of HIV-1 fusion peptide: Interaction with model membranes
dc.type
info:eu-repo/semantics/article
dc.type
info:eu-repo/semantics/acceptedVersion


Files in this item

FilesSizeFormatView

There are no files associated with this item.